Vr Adviser, LLC Celcuity Inc. Transaction History

Vr Adviser, LLC

  • $966 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$13.74 - $21.6 $12.6 Million - $19.8 Million
-915,538 Reduced 48.56%
970,000 $21 Million
Q4 2023

Feb 14, 2024
SELL
$8.7 - $15.02 $1.91 Million - $3.3 Million
-219,848 Reduced 10.44%
1,885,538 $27.5 Million
Q4 2022

Feb 14, 2023
BUY
$7.55 - $14.01 $15.9 Million - $29.5 Million
2,105,386 New
2,105,386 $29.5 Million

Others Institutions Holding CELC

# of Institutions
107
Shares Held
30.3M
Call Options Held
30.8K
Put Options Held
152K
View Full List

About Celcuity Inc.

CELC Quotes by TradingView
  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $187M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email